Page last updated: 2024-10-24

cefuroxime and Adenoma, Prostatic

cefuroxime has been researched along with Adenoma, Prostatic in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"From 33 patients with prostatic adenoma with an average age of 68."1.26[Diffusion of cefuroxime into the prostatic and other tissues of the urogenital region (author's transl)]. ( Adam, D; Boettger, F; Schalkhäuser, K, 1979)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adam, D1
Schalkhäuser, K1
Boettger, F1

Other Studies

1 other study available for cefuroxime and Adenoma, Prostatic

ArticleYear
[Diffusion of cefuroxime into the prostatic and other tissues of the urogenital region (author's transl)].
    Medizinische Klinik, 1979, Dec-07, Volume: 74, Issue:49

    Topics: Adult; Aged; Cefuroxime; Cephalosporins; Electrosurgery; Humans; Male; Middle Aged; Prostate; Prosta

1979